The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study

Treatment with pembrolizumab, an anti-programmed cell death-1 (PDCD-1) monoclonal antibody for the treatment of non-small cell lung cancers (NSCLCs) requires prior immunohistochemical (IHC) analysis of the expression of the programmed death-ligand 1 (PD-L1) (also known as CD274 molecule) which is a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Verocq, Camille, Decaestecker, Christine, Rocq, Laureen, De Clercq, Sarah, Verrellen, Audrey, Mekinda, Zita, Ocak, Sebahat, Compère, Christophe, Stanciu-Pop, Claudia, Salmon, Isabelle, Remmelink, Myriam, D'Haene, Nicky
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115063/
https://ncbi.nlm.nih.gov/pubmed/32269612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11458
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados